Amneal Pharmaceuticals In...
8.03
0.18 (2.29%)
At close: Jan 15, 2025, 12:49 PM

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14
PE Ratio -12.65 -1.18 35.37 9.83 -1.05 -10.14 11.41 7.34 47.69 n/a
PS Ratio 0.44 0.14 0.34 0.34 0.39 1.04 1.85 1.49 9.33 n/a
PB Ratio 53.70 1.63 1.94 1.95 1.84 1.92 -4.96 -8.21 -41.41 n/a
P/FCF Ratio 3.84 -11.78 3.77 2.15 -6.65 11.24 15.95 -159.43 -646.69 n/a
P/OCF Ratio 3.07 4.61 2.95 1.78 373.41 6.88 8.17 13.23 77.05 n/a
OCF/S Ratio 0.14 0.03 0.12 0.19 0.00 0.15 0.23 0.11 0.12 0.14
Debt / Equity Ratio 139.05 15.46 7.84 8.53 7.98 3.00 -3.85 n/a n/a n/a
Quick Ratio 0.94 1.17 1.52 1.57 1.51 1.50 1.64 2.04 1.55 n/a
Current Ratio 1.63 1.88 2.24 2.29 2.20 2.32 2.60 3.23 2.53 n/a
Asset Turnover 0.69 0.58 0.53 0.50 0.44 0.38 0.77 0.84 0.85 n/a
Interest Coverage 0.97 1.30 1.53 0.62 -0.82 -0.14 3.45 5.15 n/a n/a
Return on Equity (ROE) -4.25 -1.38 0.05 0.20 -1.74 -0.19 -0.43 -1.12 -0.87 n/a
Return on Assets (ROA) -0.02 -0.07 0.01 0.02 -0.16 -0.04 0.12 0.17 0.17 n/a
Return on Capital (ROIC) 0.08 0.07 0.06 0.03 -0.04 -0.01 0.23 0.29 0.29 n/a
Dividend Yield n/a n/a n/a n/a n/a 0.11 0.20 0.13 0.03 n/a
Payout Ratio n/a n/a n/a n/a n/a -1.08 2.24 0.97 1.52 1.37
Gross Profit Margin 34.28% 35.47% 36.73% 31.54% 21.70% 43.08% 50.90% 58.68% 57.63% 57.23%
Net Profit Margin -3.51% -11.52% 0.96% 3.44% -37.11% -10.21% 16.22% 20.37% 19.56% 22.52%
Pretax Profit Margin -1.68% -11.22% 1.50% -1.8% -13.54% -12.19% 16.57% 21.10% 20.27% 22.83%
Operating Profit Margin 8.54% 9.33% 9.99% 4.57% -8.45% -1.18% 23.71% 27.98% 26.23% 28.38%
FCF Margin 11.55% -1.15% 9.04% 15.70% -5.89% 9.21% 11.60% -0.94% -1.44% 4.18%
EBITDA Margin 16.70% 6.80% 21.49% 19.12% 9.54% -1.18% 26.23% 30.15% 29.17% 30.97%